299 related articles for article (PubMed ID: 8826955)
21. Long-term complications in totally implantable venous access devices: randomized study comparing subclavian and internal jugular vein puncture.
Ribeiro RC; Abib SC; Aguiar AS; Schettini ST
Pediatr Blood Cancer; 2012 Feb; 58(2):274-7. PubMed ID: 21674765
[TBL] [Abstract][Full Text] [Related]
22. Groshong catheter-associated subclavian venous thrombosis.
Gould JR; Carloss HW; Skinner WL
Am J Med; 1993 Oct; 95(4):419-23. PubMed ID: 8213875
[TBL] [Abstract][Full Text] [Related]
23. Avoiding complications of long-term venous access.
Henriques HF; Karmy-Jones R; Knoll SM; Copes WS; Giordano JM
Am Surg; 1993 Sep; 59(9):555-8. PubMed ID: 8368659
[TBL] [Abstract][Full Text] [Related]
24. Tunneled internal jugular catheters in adult patients: comparison of outcomes in hemodialysis versus infusion catheters.
Peynircioglu B; Ozkan F; Canyigit M; Cil BE; Balkanci F
Acta Radiol; 2007 Jul; 48(6):613-9. PubMed ID: 17611867
[TBL] [Abstract][Full Text] [Related]
25. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
26. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
[TBL] [Abstract][Full Text] [Related]
27. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
Templeton A; Schlegel M; Fleisch F; Rettenmund G; Schöbi B; Henz S; Eich G
Infection; 2008 Aug; 36(4):322-7. PubMed ID: 18663408
[TBL] [Abstract][Full Text] [Related]
28. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
29. [Hickman catheter for long-term parenteral therapy. A prospective interdisciplinary study].
Lang W; Schweiger H; Richter U; Richter R; Beck JD; Krasa M; Luthin D
Med Klin (Munich); 1992 Aug; 87(8):412-7. PubMed ID: 1406473
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of Groshong central venous catheters on a gynecologic oncology service.
Holloway RW; Orr JW
Gynecol Oncol; 1995 Feb; 56(2):211-7. PubMed ID: 7896188
[TBL] [Abstract][Full Text] [Related]
31. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
[TBL] [Abstract][Full Text] [Related]
32. [Encapsulated implantable venous access device: two clinical cases].
Guivarch E; Kriegel I; Bonnet L; di Maria S; Estève M
Ann Fr Anesth Reanim; 2009 Mar; 28(3):238-41. PubMed ID: 19327941
[TBL] [Abstract][Full Text] [Related]
33. The natural history of tunneled hemodialysis catheters removed or exchanged: a single-institution experience.
Alomari AI; Falk A
J Vasc Interv Radiol; 2007 Feb; 18(2):227-35. PubMed ID: 17327555
[TBL] [Abstract][Full Text] [Related]
34. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.
Lee AY; Levine MN; Butler G; Webb C; Costantini L; Gu C; Julian JA
J Clin Oncol; 2006 Mar; 24(9):1404-8. PubMed ID: 16549834
[TBL] [Abstract][Full Text] [Related]
35. [Complications of central venous and indwelling catheterization].
Douard MC; Desruennes E; Kriegel I; Blot F
Rev Prat; 2006 Jun; 56(12):1281-9. PubMed ID: 16948214
[TBL] [Abstract][Full Text] [Related]
36. Totally implantable femoral vein catheters in cancer patients.
Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
[TBL] [Abstract][Full Text] [Related]
37. Placement and management of long-term central venous access catheters and ports.
Denny DF
AJR Am J Roentgenol; 1993 Aug; 161(2):385-93. PubMed ID: 8333382
[TBL] [Abstract][Full Text] [Related]
38. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
39. Prevention of complications in permanent central venous catheters.
Takasugi JK; O'Connell TX
Surg Gynecol Obstet; 1988 Jul; 167(1):6-11. PubMed ID: 3381187
[TBL] [Abstract][Full Text] [Related]
40. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.
Biffi R; De Braud F; Orsi F; Pozzi S; Arnaldi P; Goldhirsch A; Rotmensz N; Robertson C; Bellomi M; Andreoni B
Cancer; 2001 Sep; 92(5):1204-12. PubMed ID: 11571734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
